Neogenomics (NEO) PT Raised to $16 at Benchmark
Tweet
Share
E-mailGet Alerts NEO Hot Sheet
Price: $17.56 --0%
Rating Summary:
14 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 1 | New: 13
Rating Summary:
14 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 1 | New: 13
Join SI Premium – FREE
Benchmark analyst Bruce Jackson raised the price target on Neogenomics (NASDAQ: NEO) to $16.00 (from $11.00) while maintaining a Buy rating.
You May Also Be Interested In
- Deutsche Bank Upgrades Robert Walters PLC (RWA:LN) to Buy
- Dunelm Group PLC (DNLM:LN) PT Lowered to GBP10 at Deutsche Bank
- Funding Circle Holdings Plc. (FCH:LN) (FDCHF) PT Raised to GBP3.08 at Canaccord
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
